First-Line Antibiotics for E. coli Cystitis

Recommended First-Line Options

The Infectious Diseases Society of America recommends Nitrofurantoin monohydrate/macrocrystals (100 mg twice daily for 5 days) as the preferred first-line antibiotic for treating uncomplicated cystitis caused by E. coli due to its minimal resistance patterns and limited collateral damage to normal flora 1, 2
Fosfomycin trometamol (3 g single dose) is appropriate where available, though it may have slightly inferior efficacy compared to standard short-course regimens, as suggested by the European Association of Urology 1, 3
Pivmecillinam (400 mg three times daily for 3-5 days) is recommended in regions where available (primarily European countries) by the European Association of Urology 3, 4

Trimethoprim-sulfamethoxazole (160/800 mg twice daily for 3 days) can be used if local E. coli resistance rates are below 20% or if the specific isolate is known to be susceptible, according to the Infectious Diseases Society of America 1, 5
The use of Trimethoprim-sulfamethoxazole is limited by rising resistance rates, which have reduced its utility as a first-line agent, as noted by the Infectious Diseases Society of America 5, 6

Fluoroquinolones (ciprofloxacin, levofloxacin, ofloxacin) should be reserved for situations where first-line agents cannot be used due to concerns about promoting resistance, as recommended by the Infectious Diseases Society of America and the European Association of Urology 1, 3
β-Lactams (amoxicillin-clavulanate, cefdinir, cefaclor, cefpodoxime-proxetil) can be used for 3-7 days when other recommended agents cannot be used, but generally have inferior efficacy and more adverse effects compared to other UTI antimicrobials, according to the Infectious Diseases Society of America 1, 2, 7

Amoxicillin or ampicillin should not be used for empirical treatment due to poor efficacy and very high prevalence of antimicrobial resistance worldwide, as recommended by the Infectious Diseases Society of America 1, 2

Local resistance patterns should guide therapy choice, particularly for trimethoprim-sulfamethoxazole, as suggested by the Infectious Diseases Society of America 5
Urine culture is not routinely needed for uncomplicated cystitis but should be performed if symptoms do not resolve or recur within 4 weeks after treatment, according to the European Association of Urology 3, 4
For patients whose symptoms do not resolve by the end of treatment or recur within 2 weeks, urine culture with susceptibility testing should be performed, as recommended by the European Association of Urology 4

First choice: Nitrofurantoin monohydrate/macrocrystals (100 mg twice daily for 5 days) 1
If nitrofurantoin contraindicated: Fosfomycin trometamol (3 g single dose) 3
If local resistance to TMP-SMX <20%: Consider trimethoprim-sulfamethoxazole (160/800 mg twice daily for 3 days) 1, 5
If all first-line options unavailable: Consider β-lactams or fluoroquinolones, recognizing their limitations and potential for promoting resistance 1, 7

Using fluoroquinolones as first-line therapy despite their high efficacy, as this promotes resistance to these important agents needed for more serious infections, as noted by the Infectious Diseases Society of America 1
Prescribing trimethoprim-sulfamethoxazole empirically without knowledge of local resistance patterns, as recommended by the Infectious Diseases Society of America 5
Using amoxicillin or ampicillin empirically due to high resistance rates, as recommended by the Infectious Diseases Society of America 1
Failing to adjust therapy if symptoms persist, which may indicate resistance to the chosen antibiotic, as suggested by the European Association of Urology 3, 4